Four U-M teams selected for virtual tournament of science

Anyone can vote to help studies on brain cancer, heart transplant, dementia care and deadly fungal infections advance in STAT Madness 2024

2:00 AM

Author | Kara Gavin

Illustration of scientists and doctors playing basketball in white coats and scrubs
Justine Ross

Updated, March 15: Three of the teams have received enough votes to reach the third round of the tournament. Voting ends March 21 for this round.

For basketball fans, it's almost time for March Madness, as teams vie to make the brackets of 68 teams that will compete for the national titles in men's and women's hoops. 

But for biomedical researchers, this month is time for STAT Madness, the virtual tournament of science. And four University of Michigan research teams have already made the bracket of 64 teams selected by editors at STAT News. 

They were picked for their groundbreaking work on brain cancer, heart transplant, dementia care and deadly fungal infections published in 2023.

See the 2024 STAT Madness bracket and vote now

Now, they need the public's votes to help them advance to the next round, by beating their competitors in head-to-head matchups. The competition is a friendly one, designed to increase public awareness of the importance of research on human health.

But U-M's pride is on the line, after several trips to the semifinals and a national victory in 2019.

Sign up to receive emails when a new round of voting opens.

This year's U-M entries in STAT Madness are competing under the banners of four units of the university. They are:

Michigan Medicine:

A team led by Teresa O’Meara, Ph.D., of Microbiology & Immunology, who published a paper in Science about how the deadly Candida auris fungus sticks to everything from skin to catheters, making it especially tricky to eliminate in clinical settings.

The research is described in this story, and the paper is here.

Institute for Healthcare Policy and Innovation (IHPI): 

A team led by HwaJung Choi, Ph.D., of General Medicine and Cathleen Connell, Ph.D., of the School of Public Health, who published a paper in JAMA Internal Medicine that tallies the financial toll of a dementia diagnosis on patients themselves, and the caregiving burden on the patient’s family. 

Read about the research here; read the full paper here.

Rogel Cancer Center: 

A brain cancer research team led by Neurosurgery faculty Pedro Lowenstein, M.D., Ph.D. and Maria Castro, Ph.D., and former Neurology faculty member Yoshie Umemura, M.D., who published a paper in Lancet Oncology showing promising Phase I clinical trial results from a glioma therapy based on a combination of drug therapy and immunotherapy developed at U-M.

Story about the research here and read the full paper here.

Frankel Cardiovascular Center: 

A team led by current Cardiovascular Medicine faculty Eugene Chen, M.D, Ph.D., and former Cardiac Surgery faculty Ienglam Lei, Ph.D. and Paul Tang, M.D., Ph.D, who published a paper in Science Translational Medicine about their use of a seizure medication to increase the length of time that donor hearts can be stored before transplantation. 

Read a story about the research here and the full paper here. 

 

The bracket will narrow week by week, with the final tipoff happening just around the same time that the basketball tournaments reach their final round. Anyone can vote in each round, and can sign up to receive an email when a new round begins. 

Voters are also encouraged to share the bracket on social media with the hashtag #STATMadness to encourage others to do the same.

Want to learn about what U-M's research teams are discovering all year long? Subscribe to the weekly email newsletters from the Michigan Health Lab team, or follow @umichmedscience and @umichresearch on X or Michigan Medicine on Facebook, LinkedIn, X and Instagram.


More Articles About:

Dementia All Research Topics Basic Science and Laboratory Research Heart Transplant Surgery Brain Cancer infectious disease

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related

3DModel Chest Heart EKG purple
Health Lab

Donor hearts can be reprogrammed with medication for longer storage, improved transplant outcomes

Metabolic mechanism protects hearts from damaging metabolites that build up in cold storage, study finds

Featured News & Stories

Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.
Minding memory above a microphone on a blue background
Minding Memory

Giving Voice to Lived Experience in Dementia Research

In this episode, Lauren & Matt talk to Brenda Roberts and Steven Barbieri from the National Council of Dementia Minds. The National Council of Dementia Minds is the first national not-for-profit organization founded and governed by people living with dementia. Its work focuses on education, advocacy, peer support, and changing public perception of what it means to live with dementia. Brenda and Steven talk about the National Council of Dementia Minds, the importance of peer support and education for people living with dementia. They focus on how better understanding the lived experiences of people living with dementia can help shape research, policy, and advocacy.
1906 psychopathic hospital
News Release

Exploring the mind’s mysteries: 130 years of mental health care & innovation at U-M

When it opened in 1906 on Catherine Street near the University of Michigan’s main hospitals, the stately brick State Psychopathic Hospital meant something new in the world of mental health.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.